Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Langan, Ewan A ^a,b   Vidali, Silvia ^b   Pigat, Natascha ^c   Funk, Wolfgang ^d   Lisztes, Erika ^e   Bíró, Tamás ^e   Goffin, Vincent ^c   Griffiths, Christopher E M ^a   Paus, Ralf ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

^c INSERM   (France)

^d Klinik Dr Kozlowski   (Germany)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DOPAMINE; GAMMA INTERFERON; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; EPITHELIUM; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; KERATINOCYTE; ORGAN CULTURE; PROTEIN EXPRESSION; SCALP; SKIN; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; ORGAN CULTURE TECHNIQUE; SIGNAL TRANSDUCTION;

ADULT; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; FEMALE; GENE EXPRESSION REGULATION; HAIR FOLLICLE; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PROLACTIN; RECEPTORS, PROLACTIN; SCALP; SIGNAL TRANSDUCTION; SKIN; SUBSTANCE P; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876553367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060819     Document Type: Article

References (79)

1. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, et al. (2006) Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168: 748-756.
2. Foitzik K, Krause K, Nixon AJ, Ford CA, Ohnemus U, et al. (2003) Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol 162: 1611-1621.
3. Dilme-Carreras E, Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P, (2011) Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 36: 29-32.
4. Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H, (2011) Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem 44: 1209-1213.
5. El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE, (2011) Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 50: 693-696.
6. Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R, (2010) Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21: 569-577.
7. Langan EA, Griffiths CE, Paus R, (2011) In search of the source of hyperprolactinaemia in systemic lupus erythematosus. Clin Exp Rheumatol 29: 1060.
8. Richards RG, Hartman SM, (1996) Human dermal fibroblast cells express prolactin in vitro. J Invest Dermatol 106: 1250-1255.
9. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A, (2000) Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med 136: 476-481.
10. Bjorntorp E, Wickelgren R, Bjarnason R, Swanbeck G, Carlsson LM, et al. (1997) No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis. J Invest Dermatol 109: 661-665.
11. Freeman ME, Kanyicska B, Lerant A, Nagy G, (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80: 1523-1631.
12. Ben-Jonathan N, LaPensee CR, LaPensee EW, (2008) What can we learn from rodents about prolactin in humans? Endocr Rev 29: 1-41.
13. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW, (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17: 639-669.
14. Gerlo S, Davis JR, Mager DL, Kooijman R, (2006) Prolactin in man: a tale of two promoters. Bioessays 28: 1051-1055.
15. Gellersen B, Kempf R, Telgmann R, DiMattia GE, (1994) Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 8: 356-373.
16. Ferraris J, Boutillon F, Bernadet M, Seilicovich A, Goffin V, et al. (2012) Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab 302: E356-364.
17. Langan EA, Griffiths CE, Paus R, (2012) Utilizing the hair follicle to dissect the regulation and autocrine/paracrine activities of prolactin in humans. Am J Physiol Endocrinol Metab 302: E1311-1312.
18. Bernichtein S, Touraine P, Goffin V, (2010) New concepts in prolactin biology. J Endocrinol 206: 1-11.
19. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA, (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19: 225-268.
20. Langan EA, Ramot Y, Hanning A, Poeggeler B, Biro T, et al. (2010) Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol 162: 1127-1131.
21. Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, et al. (2010) Prolactin-a novel neuroendocrine regulator of human keratin expression in situ. Faseb J 24: 1768-1779.
22. Slominski A, (2005) Neuroendocrine system of the skin. Dermatology 211: 199-208.
23. Zouboulis CC, (2004) The human skin as a hormone target and an endocrine gland. Hormones (Athens) 3: 9-26.
24. Zmijewski MA, Slominski AT, (2011) Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol 3: 3-10.
25. Slominski A, Wortsman J, (2000) Neuroendocrinology of the skin. Endocr Rev 21: 457-487.
26. Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, et al. (2012) Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol 212: v, vii, 1-115.
27. Foitzik K, Langan EA, Paus R, (2009) Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 129: 1071-1087.
28. Langan EA, Griffiths CE, Paus R, (2012) Exploring the role of prolactin in psoriasis. Arch Dermatol Res 304: 115-118.
29. Lutz G, (2012) Hair loss and hyperprolactinemia in women. Dermatoendocrinol 4: 65-71.
30. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, et al. (1998) Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 83: 667-674.
31. Maaskant RA, Bogic LV, Gilger S, Kelly PA, Bryant-Greenwood GD, (1996) The human prolactin receptor in the fetal membranes, decidua, and placenta. J Clin Endocrinol Metab 81: 396-405.
32. Lu Z, Hasse S, Bodo E, Rose C, Funk W, et al. (2007) Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 16: 37-44.
33. Peters EM, Liotiri S, Bodo E, Hagen E, Biro T, et al. (2007) Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 171: 1872-1886.
34. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, et al. (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. Faseb J 19: 1332-1334.
35. van Beek N, Bodo E, Kromminga A, Gaspar E, Meyer K, et al. (2008) Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab 93: 4381-4388.
36. Bodo E, Kany B, Gaspar E, Knuver J, Kromminga A, et al. (2010) Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology 151: 1633-1642.
37. Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, et al. (2011) Dopamine receptors in human adipocytes: expression and functions. PLoS One 6: e25537.
38. Philpott MP, Sanders DA, Bowen J, Kealey T, (1996) Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol 135: 942-948.
39. Ito T, Ito N, Saathoff M, Bettermann A, Takigawa M, et al. (2005) Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol 152: 623-631.
40. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, et al. (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164: 623-634.
41. Bernichtein S, Kayser C, Dillner K, Moulin S, Kopchick JJ, et al. (2003) Development of pure prolactin receptor antagonists. J Biol Chem 278: 35988-35999.
42. Limat A, Noser FK, (1986) Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles. J Invest Dermatol 87: 485-488.
43. Bodo E, Kromminga A, Biro T, Borbiro I, Gaspar E, et al. (2009) Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol 129: 1126-1139.
44. Morel G, Enjalbert A, Proulx L, Pelletier G, Barden N, et al. (1989) Effect of corticotropin-releasing factor on the release and synthesis of prolactin. Neuroendocrinology 49: 669-675.
45. Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, et al. (1998) Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells? Clin Endocrinol (Oxf) 49: 433-439.
46. Vankelecom H, Matthys P, Denef C, (1997) Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Mol Cell Endocrinol 129: 157-167.
47. Yamaguchi M, Koike K, Matsuzaki N, Yoshimoto Y, Taniguchi T, et al. (1991) The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro. J Endocrinol Invest 14: 457-461.
48. Cano P, Cardinali DP, Jimenez V, Alvarez MP, Cutrera RA, et al. (2005) Effect of interferon-gamma treatment on 24-hour variations in plasma ACTH, growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone of male rats. Neuroimmunomodulation 12: 146-151.
49. Harel G, Shamoun DS, Kane JP, Magner JA, Szabo M, (1995) Prolonged effects of tumor necrosis factor-alpha on anterior pituitary hormone release. Peptides 16: 641-645.
50. Krueger JG, (2012) Hiding under the skin: A welcome surprise in psoriasis. Nat Med 18: 1750-1751.
51. Griffiths CE, Barker JN, (2007) Pathogenesis and clinical features of psoriasis. Lancet 370: 263-271.
52. Giasuddin AS, El-Sherif AI, El-Ojali SI, (1998) Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 197: 119-122.
53. Sanchez Regana M, Umbert Millet P, (2000) Psoriasis in association with prolactinoma: three cases. Br J Dermatol 143: 864-867.
54. Golander A, Barrett J, Hurley T, Barry S, Handwerger S, (1979) Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro. J Clin Endocrinol Metab 49: 787-789.
55. Burris TP, Nguyen DN, Smith SG, Freeman ME, (1992) The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins. Endocrinology 130: 926-932.
56. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, et al. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179-186.
57. Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K, (2001) Immunolocalisation of the janus kinases (JAK)-signal transducers and activators of transcription (STAT) pathway in human epidermis. J Anat 198: 581-589.
58. Gaspar E, Hardenbicker C, Bodo E, Wenzel B, Ramot Y, et al. (2010) Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. Faseb J 24: 393-403.
59. Samuelov L, Sprecher E, Tsuruta D, Biro T, Kloepper JE, et al. (2012) P-Cadherin Regulates Human Hair Growth and Cycling via Canonical Wnt Signaling and Transforming Growth Factor-beta2. J Invest Dermatol.
60. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, et al. (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164: 1292-1298.
61. Langan EA, Lisztes E, Biro T, Funk W, Kloepper JE, et al. (2012) Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro. Br J Dermatol.
62. Gaspar E, Nguyen-Thi KT, Hardenbicker C, Tiede S, Plate C, et al. (2011) Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol 131: 2368-2377.
63. Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, et al. (2009) Re-evaluation of the prolactin receptor expression in human breast cancer. J Endocrinol 201: 115-128.
64. Katznelson L, Riskind PN, Saxe VC, Klibanski A, (1998) Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab 83: 761-764.
65. Zinger M, McFarland M, Ben-Jonathan N, (2003) Prolactin expression and secretion by human breast glandular and adipose tissue explants. J Clin Endocrinol Metab 88: 689-696.
66. Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D, et al. (1996) The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1289: 247-251.
67. Pisarchik A, Slominski AT, (2001) Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. Faseb J 15: 2754-2756.
68. Dorshkind K, Horseman ND, (2001) Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23: 288-294.
69. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schaufele M, et al. (1994) Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 103: 530-533.
70. Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, et al. (2008) Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128: 434-446.
71. Arisawa M, Snyder GD, Yu WH, De Palatis LR, Ho RH, et al. (1990) Physiologically significant inhibitory hypothalamic action of substance P on prolactin release in the male rat. Neuroendocrinology 52: 22-27.
72. Girolomoni G, Phillips JT, Bergstresser PR, (1993) Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol 101: 275-279.
73. Clapp C, Thebault S, Martinez de la Escalera G, (2008) Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland. J Mammary Gland Biol Neoplasia 13: 55-67.
74. Langan EA, Paus R (2010) Female pattern hair loss: beyond an androgenic aetiology? Br J Dermatol 163: 1140-1141; author reply 1141-1142.
75. Langan EA, Ramot Y, Goffin V, Griffiths CE, Foitzik K, et al. (2010) Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol 130: 886-891.
76. Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, et al. (2009) Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39: 996-1006.
77. Kanda N, Watanabe S, (2007) Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148: 2317-2325.
78. Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, et al. (2001) Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 44: 2358-2366.
79. Stevens A, Ray DW, Worthington J, Davis JR, (2001) Polymorphisms of the human prolactin gene-implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10: 676-683.